Cargando…
CD157: From Myeloid Cell Differentiation Marker to Therapeutic Target in Acute Myeloid Leukemia
Human CD157/BST-1 and CD38 are dual receptor-enzymes derived by gene duplication that belong to the ADP ribosyl cyclase gene family. First identified over 30 years ago as Mo5 myeloid differentiation antigen and 10 years later as Bone Marrow Stromal Cell Antigen 1 (BST-1), CD157 proved not to be rest...
Autores principales: | Yakymiv, Yuliya, Augeri, Stefania, Fissolo, Giulia, Peola, Silvia, Bracci, Cristiano, Binaschi, Monica, Bellarosa, Daniela, Pellacani, Andrea, Ferrero, Enza, Ortolan, Erika, Funaro, Ada |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6952987/ https://www.ncbi.nlm.nih.gov/pubmed/31817547 http://dx.doi.org/10.3390/cells8121580 |
Ejemplares similares
-
CD157 signaling promotes survival of acute myeloid leukemia cells and modulates sensitivity to cytarabine through regulation of anti-apoptotic Mcl-1
por: Yakymiv, Yuliya, et al.
Publicado: (2021) -
Soluble CD157 in pleural effusions: a complementary tool for the diagnosis of malignant mesothelioma
por: Augeri, Stefania, et al.
Publicado: (2018) -
CD157 enhances malignant pleural mesothelioma aggressiveness and predicts poor clinical outcome
por: Ortolan, Erika, et al.
Publicado: (2014) -
Human canonical CD157/Bst1 is an alternatively spliced isoform masking a previously unidentified primate-specific exon included in a novel transcript
por: Ferrero, Enza, et al.
Publicado: (2017) -
Overexpression of CD157 Contributes to Epithelial Ovarian Cancer Progression by Promoting Mesenchymal Differentiation
por: Morone, Simona, et al.
Publicado: (2012)